Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
نویسندگان
چکیده
E. Gutiérrez-Rivas1,*, J. Bautista2, J.J. Vílchez3, N. Muelas3, J. Díaz-Manera4, I. Illa4, A. Martínez-Arroyo5, M. Olivé5, I. Sanz6, J. Arpa6, R. Fernández-Torrón7, A. López de Munáin7, L. Jiménez8, J. Solera9 and Z. Lukacs10 Department of Neurology, 12 de Octubre Hospital, Madrid, Spain Department of Neurology, Sagrado Corazón Clinic, Seville, Spain La Fe Hospital, Valencia, Spain Department of Neurology, Santa Creu i Sant Pau Hospital, Barcelona, Spain Neuropathology Institute IDIBELL, Bellvitge Hospital, Barcelona, Spain Department of Neurology, La Paz Hospital, Madrid, Spain Department of Neurology, Donostia Hospital, San Sebastián, Spain Clinical Biochemistry Section, Virgen del Rocío Hospital, Seville, Spain Molecular Oncogenetic Unit, Institute of Medical and Molecular Genetics, La Paz Hospital, Madrid, Spain Institute of Clinical Chemistry and Department of Pediatrics, Hamburg University Medical Center, Hamburg, Germany Journal of Neuromuscular Diseases 1 (2015) S42 DOI 10.3233/JND-159038 IOS Press
منابع مشابه
Late-onset Pompe Disease with Elevated Liver Transaminases: A Case Report
Pompe disease or type II glycogen storage disease is a rare autosomal hereditary disease. The prevalence of the disease is about 1 in 40,000 to 1 in 300,000 population. It usually occurs as a result of glycogen accretion following acid maltase deficiency. The current treatment is enzyme replacement therapy, which may slow down the disease progression. Sometimes, the clinical presentation can be...
متن کاملA large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
The aim of this study was to: (a) analyze the results of a large-scale newborn screening program for Pompe disease, and (b) establish an effective diagnostic protocol to obtain immediate, valid diagnosis of infantile-onset Pompe disease (IOPD) to promote earlier treatment and better outcomes. In this study, 402,281 newborns were screened for Pompe disease from January 1, 2008 to May 1, 2012. In...
متن کاملLOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population.
OBJECTIVE A multicentre observational study was aimed to assess the prevalence of late-onset Pompe disease (LOPD) in a large high-risk population, using the dried blood spot (DBS) as a main screening tool. DESIGN/METHODS 17 Italian neuromuscular centres were involved in the late-onset Pompe early diagnosis (LOPED) study. Inclusion criteria were: (1) age ≥5 years, (2) persistent hyperCKaemia a...
متن کاملLimitations of muscle biopsy in Pompe disease
The diagnosis of Pompe disease in children and adults can be challenging because of the heterogeneous clinical presentation and considerable overlap of signs and symptoms found in other neuromuscular diseases. This review evaluates the use of muscle biopsy and other methods for the diagnosis and differential diagnosis of late-onset Pompe disease. Muscle biopsy is commonly used as an early diagn...
متن کاملClinical guidelines for late-onset Pompe disease.
Before 2006, Pompe disease or glycogenosis storage disease type II was an incurable disease whose treatment was merely palliative. The development of a recombinant human alpha-glucosidase enzymatic replacement therapy has become the first specific treatment for this illness. The aim of this guide is to serve as reference for the management of the late-onset Pompe disease, the type of Pompe dise...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of neuromuscular diseases
دوره 2 s1 شماره
صفحات -
تاریخ انتشار 2015